GlassScriptPhysician profile
Sabena K Ramsetty
NPI 1659553394
$18,524.43
in general payments reported to CMS, 2019-2025
15 companies · $756 in 2025
The $756 reported for 2025 was more than what 75% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $4,725 · 2021: $5,912 · 2022: $5,352 · 2023: $447 · 2024: $505 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $10,192.41 | 2021-2025 | |
| Allergan, INC. | $5,935.11 | 2019-2021 | |
| Gilead Sciences, INC. | $1,008.50 | 2019-2025 | Yeztugo, Biktarvy |
| Viiv Healthcare Company | $453.22 | 2019-2025 | Cabenuva, Apretude, Dovato |
| Glaxosmithkline, LLC. | $250.45 | 2022-2023 | Arexvy |
| Lilly USA, LLC | $152.60 | 2024-2025 | Zepbound |
| Tactile Systems Technology INC | $148.49 | 2024 | Entre Plus, Flexitouch Plus |
| Philips North America LLC | $97.49 | 2024 | (9274) Lld |
| Merck Sharp & Dohme LLC | $90.29 | 2023-2025 | Pifeltro, Zerbaxa, Dificid |
| Cumberland Pharmaceuticals, INC. | $62.02 | 2022-2024 | Vibativ |
| Exact Sciences Corporation | $50.36 | 2023-2024 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $38.11 | 2025 | Vowst |
| Amgen INC. | $16.01 | 2023 | Prolia, Evenity |
| Seqirus USA INC | $15.99 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Angiodynamics, INC. | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabena Ramsetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.